{"id":"W2007390314","doi":"10.1016/s1474-4422(11)70012-6","title":"Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":195,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"ACADIA Pharmaceuticals; Ministero dell’Istruzione, dell’Università e della Ricerca; National Parkinson Foundation; Novartis; Genzyme; National Institute of Mental Health; Schering-Plough","keywords":"Parkinson's disease; Double blind; Physical medicine and rehabilitation; Medicine; Phase (matter); Physical therapy; Disease; Internal medicine; Physics; Alternative medicine; Placebo; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000146134,0.0001132078,0.0001734092,0.00003196488,0.00005035479,0.000008526499,0.0001477791,0.00006439994,0.00002065681],"category_scores_gemma":[0.00004567177,0.00006955132,0.00002880579,0.00005199516,0.00009238877,0.000004230332,0.00005683532,0.000112184,0.000002059523],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001514798,"about_ca_system_score_gemma":0.00003299259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001370669,"about_ca_topic_score_gemma":0.000006034232,"domain_scores_codex":[0.9992072,0.0001273036,0.0001489422,0.0002452277,0.00006808073,0.0002032588],"domain_scores_gemma":[0.999543,0.00002874246,0.00007391303,0.0002688186,0.00002591851,0.00005965747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.986234,0.0002649956,0.01203922,0.000005905631,0.00003982521,0.0000127048,0.0001019346,0.00001624926,0.0005118345,0.00005303824,0.0005503281,0.0001699267],"study_design_scores_gemma":[0.9338408,0.003303856,0.05433895,0.000006330967,0.00008467373,0.000005433171,0.000005785404,0.00008015108,0.0006917912,0.0001943014,0.007258034,0.0001898625],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997921,0.0004625209,0.00009342125,0.0003868554,0.00008357484,0.0009021484,0.00001188582,0.00000845464,0.0001301387],"genre_scores_gemma":[0.998511,0.00009144006,0.00004175869,0.0007607156,0.0003176346,0.0001749367,0.00004503794,0.00001348123,0.00004401748],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05239321,"threshold_uncertainty_score":0.283622,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03210741335143601,"score_gpt":0.2631726952557821,"score_spread":0.2310652819043461,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}